Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms

References

• Yao J, Hassan M, Dagohoy A. C, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063. doi:10.1200/JCO.2007.15.437718565894
   PubMed Web of Science ®Google Scholar
• Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2015;50(1):58–64. doi:10.1007/s00535-014-0934-224499825
   PubMed Web of Science ®Google Scholar
• Halfdanarson TR, Rabe KG, Rubin J, et al. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008;19(10):1727–1733. doi:10.1093/annonc/mdn35118515795
   PubMed Web of Science ®Google Scholar
• Ohmoto A, Rokutan H, Yachida S. Pancreatic Neuroendocrine Neoplasms: basic Biology, Current Treatment Strategies and Prospects for the Future. Int J Mol Sci. 2017;18(1):143. doi:10.3390/ijms18010143
   PubMed Web of Science ®Google Scholar
• Sun J. Pancreatic neuroendocrine tumors. Intractable Rare Dis Res. 2017;6(1):21–28. doi:10.5582/irdr.2017.0100728357177
   PubMed Web of Science ®Google Scholar
• Luo G, Javed A, Strosberg JR, et al. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems. J Clin Oncol. 2017;35(3):274–280. doi:10.1200/JCO.2016.67.819327646952
   PubMed Web of Science ®Google Scholar
• Botling J, Lamarca A, Bajic D, et al. High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors.. Neuroendocrinology. 2020;110(11–12):891–898. doi:10.1159/00050439231658459
   PubMed Web of Science ®Google Scholar
• Milione M, Maisonneuve P, Spada F, et al. The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: morphological Differentiation and Proliferation Identify Different Prognostic Categories. Neuroendocrinology. 2017;104(1):85–93. doi:10.1159/00044516526943788
   PubMed Web of Science ®Google Scholar
• Sandini M, Strobel O, Hank T, et al. Pre-operative dysglycemia is associated with decreased survival in patients with pancreatic neuroendocrine neoplasms. Surgery. 2020;167(3):575–580. doi:10.1016/j.surg.2019.11.00731889543
   PubMed Web of Science ®Google Scholar
• Tong Z, Liu L, Zheng Y, et al. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study. World J Surg Oncol. 2017;15(1):108. doi:10.1186/s12957-017-1169-528558772
   PubMed Web of Science ®Google Scholar
• Weisel JW, Litvinov RI. Fibrin Formation, Structure and Properties. Subcell Biochem. 2017;82:405–456.28101869
   PubMedGoogle Scholar
• Halper J, Kjaer M. Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins. Adv Exp Med Biol. 2014;802:31–47.24443019
   PubMed Web of Science ®Google Scholar
• Luyendyk JP, Schoenecker JG, Flick MJ. The multifaceted role of fibrinogen in tissue injury and inflammation. Blood. 2019;133(6):511–520. doi:10.1182/blood-2018-07-81821130523120
   PubMed Web of Science ®Google Scholar
• Hoppe B, Häupl T, Skapenko A, et al. Fibrinogen and factor XIII A-subunit genotypes interactively influence C-reactive protein levels during inflammation. Ann Rheum Dis. 2012;71(7):1163–1169. doi:10.1136/annrheumdis-2011-20073822267327
   PubMed Web of Science ®Google Scholar
• Wang M, Zhang G, Zhang Y, et al. Fibrinogen Alpha Chain Knockout Promotes Tumor Growth and Metastasis through Integrin-AKT Signaling Pathway in Lung Cancer. Mol Cancer Res. 2020.
   Web of Science ®Google Scholar
• Adams GN, Rosenfeldt L, Frederick M, et al. Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen. Cancer Res. 2015;75(19):4235–4243. doi:10.1158/0008-5472.CAN-15-096426238780
   PubMed Web of Science ®Google Scholar
• Caraceni P, Tufoni M, Bonavita ME. Clinical use of albumin.. Blood Transfus. 2013;11 Suppl 4:S18–S25. doi:10.2450/2013.005s24333308
   PubMed Web of Science ®Google Scholar
• Rogers PCJ. Nutritional status as a prognostic indicator for pediatric malignancies. J Clin Oncol. 2014;32(13):1293–1294. doi:10.1200/JCO.2014.55.061624687820
   PubMed Web of Science ®Google Scholar
• Fan Z, Fan K, Gong Y, et al. <p>The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer. Cancer Manag Res. 2019;11:8781–8788. doi:10.2147/CMAR.S21136331632137
   PubMed Web of Science ®Google Scholar
• Tan Z, Zhang M, Han Q, et al. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio. J Cancer. 2017;8(6):1025–1029. doi:10.7150/jca.1649128529615
   PubMed Web of Science ®Google Scholar
• Liang Y, Wang W, Que Y, et al. Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma. BMC Cancer. 2018;18(1):942. doi:10.1186/s12885-018-4856-x30285656
   PubMed Web of Science ®Google Scholar
• Xu Q, Yan Y, Gu S, et al. A Novel Inflammation-Based Prognostic Score: the Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma. J Immunol Res. 2018;2018:4925498. doi:10.1155/2018/492549830027102
   PubMed Web of Science ®Google Scholar
• Zhang J, Ding Y, Wang W, et al. Combining the Fibrinogen/Albumin Ratio and Systemic Inflammation Response Index Predicts Survival in Resectable Gastric Cancer. Gastroenterol Res Pract. 2020;2020:3207345. doi:10.1155/2020/320734532184816
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao G. <p>Prognostic significance of the ratio of fibrinogen and albumin in human malignancies: a meta-analysis. Cancer Manag Res. 2019;11:3381–3393. doi:10.2147/CMAR.S19841931114374
   PubMed Web of Science ®Google Scholar
• Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31(12):1770–1786. doi:10.1038/s41379-018-0110-y30140036
   PubMed Web of Science ®Google Scholar
• Nishino M, Jagannathan JP, Ramaiya NH, et al. Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know. AJR Am J Roentgenol. 2010;195(2):281–289. doi:10.2214/AJR.09.411020651182
   PubMed Web of Science ®Google Scholar
• Baur AD, Pavel M, Prasad V, et al. Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment. Acta Radiol. 2016;57(3):260–270. doi:10.1177/028418511557993225855665
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang F, Huang Y, et al. <p>FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition. Cancer Manag Res. 2019;11:1653–1665. doi:10.2147/CMAR.S18824830863175
   PubMed Web of Science ®Google Scholar
• Sahni A, Simpson-haidaris PJ, Sahni SK, et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost. 2007;6(1):176–183. doi:10.1111/j.1538-7836.2007.02808.x17949478
   PubMed Web of Science ®Google Scholar
• Palumbo JS, Talmage KE, Massari JV, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cells. Blood. 2005;105(1):178–185. doi:10.1182/blood-2004-06-227215367435
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wu C, Yan H, et al. Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study. Clin Chim Acta. 2020;506:110–121. doi:10.1016/j.cca.2020.03.01132156604
   PubMed Web of Science ®Google Scholar
• Ridker PM, Howard CP, Walter V, et al. Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation. 2012;126(23):2739–2748. doi:10.1161/CIRCULATIONAHA.112.12255623129601
   PubMed Web of Science ®Google Scholar
• Hülshoff A, Schricker T, Elgendy H, et al. Albumin synthesis in surgical patients. Nutrition. 2013;29(5):703–707. doi:10.1016/j.nut.2012.10.01423333435
   PubMed Web of Science ®Google Scholar
• Baracos VE. Cancer-associated malnutrition. Eur J Clin Nutr. 2018;72(9):1255–1259. doi:10.1038/s41430-018-0245-430185853
   PubMed Web of Science ®Google Scholar
• Hu W-H, Eisenstein S, Parry L, et al. Preoperative malnutrition with mild hypoalbuminemia associated with postoperative mortality and morbidity of colorectal cancer: a propensity score matching study. Nutr J. 2019;18(1):33. doi:10.1186/s12937-019-0458-y31253199
   PubMed Web of Science ®Google Scholar
• Lim WS, Roh J-L, Kim S-B, et al. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma. Laryngoscope. 2017;127(12):E437–E442. doi:10.1002/lary.2669128561532
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang Y, Huang Z, et al. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy. World J Surg. 2020;44(6):1975–1984. doi:10.1007/s00268-020-05407-332020327
   PubMed Web of Science ®Google Scholar